Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

Authors:
  • ANArthur A. Nagel
    Arthur A. Nagel
  • JBJon Bordner
    Jon Bordner
  • KDKishor A. Desai
    Kishor A. Desai
  • JDJoseph N. Dibrino
    Joseph N. Dibrino
  • JNJolanta Nowakowska
    Jolanta Nowakowska
  • LVLawrence Vincent
    Lawrence Vincent
  • RWRichard M. Watrous
    Richard M. Watrous
  • FSFrank C. Sciavolino
    Frank C. Sciavolino
  • AEArthur R. English
    Arthur R. English
  • JRJames A. Retsema
    James A. Retsema
  • MAMargaret R. Anderson
    Margaret R. Anderson

Abstract
A series of erythromycin A-derived semisynthetic antibiotics, featuring incorporation of a basic nitrogen atom into a ring expanded (15-membered) macrocyclic lactone, have been prepared and biologically evaluated. Semisynthetic modifications focused upon (1) varied substitution at the macrocyclic ring nitrogen and (2) epimerization or amine substitution at the C-4'' hydroxyl site within the cladinose sugar. In general, the new azalides exhibit improved Gram-negative potency, expanding the spectrum of erythromycin A to fully include Haemophilus influenzae and Neisseria gonorrhoeae. When compared to erythromycin A, the azalides exhibit substantially increased half-life and area-under-the-curve values in all species studied. The overall in vitro/in vivo performance of N-methyl, C-4'' epimers 3a and 9; and C-4'' amine 11 identify these compounds as the most interesting erythromycin A-superior agents. Compound 3a has been advanced to clinical study.

This publication has 7 references indexed in Scilit: